| Literature DB >> 34566411 |
Pia Andersson1, Annika Kragh Ekstam2.
Abstract
INTRODUCTION: Fall-related injuries are prevalent in older patients and often lead to increased morbidity, medication, and impaired functions. We studied older trauma patients with the aim to describe their oral health in comparison to morbidity and medication.Entities:
Keywords: DFT; comorbidity; medication; oral health; orthogeriatric patients; risk factors
Mesh:
Substances:
Year: 2021 PMID: 34566411 PMCID: PMC8457442 DOI: 10.2147/CIA.S326095
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Baseline Characteristics, Total and in Relation to Gender and Age Groups, 198 Patients, Number of Patients (%)
| Variable | Total | Women | Men | p-value | 65–79 Years | ≥80 Years | p-value |
|---|---|---|---|---|---|---|---|
| N=198 | N=140 (71) | n=58 (29) | N=82 (41) | N=116 (59) | |||
| Comorbidities | |||||||
| Dementia | 28 (14) | 19 (15) | 9 (15.5) | 0.721 | 6 (7) | 22 (19) | |
| Diabetes mellitus | 33 (17) | 18 (13) | 15 (26) | 15 (18) | 18 (15.5) | 0.606 | |
| Heart disease | 79 (40) | 50 (36) | 29 (50) | 0.062 | 23 (28) | 56 (48) | |
| COPD | 24 (13) | 17 (13) | 7 (13) | 0.879 | 8 (10) | 17 (15) | 0.307 |
| RA | 12 (6) | 12 (9) | 0 (0) | 6 (7) | 6 (5) | 0.533 | |
| CCI >mean, 6.67, age-adjusted | 98 (50) | 68 (49) | 30 (52) | 0.686 | 17 (21) | 81 (70) | NA |
| Medications | |||||||
| Number of drugsa | |||||||
| Mean (SD) | 6.8 (4.5) | 6.9 (4.6) | 6.7 (4.3) | 0.746 | 6.4 (4.6) | 7.2 (4.3) | 0.219 |
| Polypharmacyb 5 | 130 (66) | 91 (65) | 39 (67) | 0.762 | 48 (58) | 82 (71) | 0.076 |
| Polypharmacyb 10 | 46 (23) | 34 (24) | 12 (21) | 0.586 | 18 (22) | 28 (24) | 0.720 |
| Diuretics | 71 (36) | 49 (35) | 22 (38) | 0.746 | 21 (26) | 50 (43) | |
| Antipsychotics | 14 (7) | 8 (6) | 6 (10) | 0.360 | 4 (5) | 10 (9) | 0.404 |
| Opioids | 19 (10) | 14 (10) | 5 (9) | 0.764 | 6 (7) | 13 (11) | 0.360 |
| Anticoagulants | 98 (49.5) | 65 (46) | 33 (57) | 0.180 | 32 (39) | 66 (57) | |
| Antidepressants | 48 (24) | 38 (27) | 10 (17) | 0.139 | 18 (22) | 30 (26) | 0.527 |
| PPI | 57 (29) | 43 (31) | 14 (24) | 0.352 | 28 (34) | 29 (25) | 0.161 |
| Inhalation drugsc | 36 (18) | 25 (18) | 11 (19) | 0.854 | 16 (19.5) | 20 (17) | 0.683 |
| ACE/ARB | 63 (35) | 43 (34) | 20 (37) | 0.681 | 25 (32) | 38 (37) | 0.432 |
| Sedatives | 52 (29) | 38 (30) | 14 (26) | 0.587 | 18 (23) | 34 (33) | 0.120 |
| Anticholinergicsd | 20 (10) | 15 (11) | 5 (9) | 0.070 | 7 (8.5) | 13 (11) | 0.782 |
| Use of ≥2 drugs with strong anticholinergic effect | 14 (7) | 13 (9) | 1 (2) | 0.656 | 5 (6) | 9 (8) | 0.539 |
Notes: aUsed on a regular basis, drugs as per needed are not included. bPolypharmacy 5, defined as use of 5 or more drugs regularly and severe polypharmacy defined as use of 10 or more drugs regularly. cDrugs used for obstructive lung diseases. dDrugs with strong anticholinergic effects. P-values of <0.005 are presented in bold text.
Abbreviations: NA, not applicable; COPD, chronic obstructive pulmonary disease; RA, rheumatoid arthritis; CCI, age adjusted Charlson comorbidity index; PPI, proton pump inhibitors; eGFR, estimated glomerular filtration rate; ACE/ARB, angiotensin converting enzyme inhibitor/angiotensin II receptor blocker.
Oral Health Status in Dentate Patients, Total and in Relation to Gender and Age Groups (n=181).
| Variable | Total | Women | Men | p-value | 65–79 Years | ≥80 Years | p-value |
|---|---|---|---|---|---|---|---|
| N=181 | N=102 | N=54 | N=79 | N=102 | |||
| <20 teeth, n (%) | 80 (44) | 57 (45) | 23 (43) | 0.777 | 29 (37) | 51 (50) | 0.074 |
| Decayed teeth mean (SD) | 0.7 (1.9) | 0.6 (1.9) | 0.9 (2.1) | 0.421 | 0.6 (2.2) | 0.7 (1.7) | 0.786 |
| Missing teeth mean (SD) | 8.8 (6.5) | 8.5 (6.3) | 9.5 (6.9) | 0.319 | 7.5 (6.5) | 9.8 (6.4) | |
| Filled teeth | 14.1 (6.1) | 14.7 (5.8) | 12.9 (6.6) | 0.080 | 15.0 (6.1) | 13.5 (6.1) | 0.090 |
| DFT mean (SD) | 14.8 (5.8) | 15.3 (5.5) | 13.8 (6.3) | 0.114 | 15.7 (5.6) | 14.2 (5.9) | 0.089 |
| Pocket depth ≥4 mm, mean (SD) | 5.3 (5.1) | 4.8 (4.7) | 6.6 (5.8) | 5.5 (5.1) | 5.2 (5.1) | 0.701 |
Note: P-values of <0.005 are presented in bold text.
Abbreviations: SD, standard deviation; DFT, Decayed Filled Teeth.
Oral Health Status in Dentate Patients, in Relation to Comorbidities and Medications (n=181)
| Variable | Number of Teeth | Pocket Depth | DFT |
|---|---|---|---|
| < 20 Teeth | ≥ 4 mm | > Mean 15 | |
| N= 80 (44%) | N= 147 (81%) | N= 94 (52%) | |
| Comorbidities | |||
| Diabetes | 0.58 (0.25–1.39) | 0.68 (0.21–2.22) | 0.37 (0.15–0.94) |
| p-value | 0.224 | 0.520 | |
| Heart disease | 1.26 (0.64–2.44) | 0.38 (0.15–0.95) | 0.99 (0.51–1.94) |
| p-value | 0.505 | 0.997 | |
| Dementia | 0.82 (0.32–2.07) | 0.89 (0.27–2.93) | 0.75 (0.29–1.96) |
| p-value | 0.673 | 0.849 | 0.556 |
| COPD | 0.33 (0.13–0.83) | 1.03 (0.32–3.35) | 0.36 (0.13–0.99) |
| p-value | 0.961 | ||
| Medications | |||
| Polypharmacy ≥5a | 0.62 (0.31–1.24) | 0.56 (0.24–1.28) | 0.40 (0.20–0.81) |
| p-value | 0.176 | 0.167 | |
| Diuretics | 0.62 (0.32–1.20) | 0.32 (0.12–0.86) | 0.39 (0.20–0.78) |
| p-value | 0.158 | ||
| Anticoagulants | 1.13 (0.60–2.12) | 0.47 (0.21–1.07) | 0.77 (0.41–1.44) |
| p-value | 0.710 | 0.073 | 0.414 |
| Inhalation drugsb | 0.29 (0.12–0.67) | 1.97 (0.80–4.85) | 0.41 (0.18–0.93) |
| p-value | 0.138 | ||
| ACE/ARB | 1.65 (0.87–3.14) | 0.63 (0.27–1.46) | 0.61 (0.32–1.15) |
| p-value | 0.128 | 0.286 | 0.127 |
| Sedatives | 0.78 (0.39–1.54) | 0.67 (0.27–1.65) | 0.57 (0.28–1.14) |
| p-value | 0.468 | 0.382 | 0.113 |
| Anticholinergicsc | 0.49 (0.14–1.64) | 0.71 (0.14–3.46) | 0.62 (0.19–2.07) |
| p-value | 0.245 | 0.669 | 0.440 |
| Use of ≥2 AC drugsd,* | 0.32 (0.15–0.70) | 1.76 (0.71–4.34) | 0.31 (0.14–0.66) |
| p-value | 0.149 | ||
Notes: aPolypharmacy, defined as use of 5 or more drugs regularly. bInhalation drugs used for obstructive lung diseases. cDrugs with strong anticholinergic effect. dPatients using two or more drugs with strong anticholinergic effect. All variables were adjusted for age, gender, and comorbidity index (CCI), and the variable marked with *was also adjusted for polypharmacy. Values presented as OR (95% CI). P-values of <0.005 are presented in bold text.
Abbreviations: OR, odds ratio; CI, Confidence interval; COPD, chronic obstructive pulmonary disease; RA, rheumatoid arthritis; CCI, Charlson comorbidity index; eGFR, Estimated glomerular filtration rate; ACE/ARB, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers; AC, strong anticholinergic drugs.